Replies to post #108163 on Biotech Values

[DewDiligence]

VRTX—Does anyone know the reason for the sell-off?

VRTX is down less than 1% today as I’m typing, so I presume you’re referring to the 10% swoon during November. This can be attributed to sector underperformance by pharma since the election (#msg-56315608) and, to a lesser degree, to impressive HCV data by B-I at AASLD (#msg-56271789). Regards, Dew